| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 307.91B | 323.38B | 333.63B | 308.69B | 299.80B |
| Gross Profit | 93.78B | 87.13B | 82.66B | 76.68B | 82.04B |
| EBITDA | 40.02B | 32.95B | 42.19B | 36.07B | 172.36B |
| Net Income | 15.70B | 10.12B | 14.55B | 9.46B | 64.82B |
Balance Sheet | |||||
| Total Assets | 463.99B | 445.54B | 422.06B | 459.29B | 481.72B |
| Cash, Cash Equivalents and Short-Term Investments | 73.34B | 74.48B | 77.83B | 124.41B | 112.77B |
| Total Debt | 59.80B | 45.84B | 32.43B | 31.35B | 27.32B |
| Total Liabilities | 175.16B | 158.27B | 146.17B | 196.06B | 226.72B |
| Stockholders Equity | 271.93B | 270.09B | 260.47B | 248.70B | 239.91B |
Cash Flow | |||||
| Free Cash Flow | 19.62B | 1.75B | -11.40B | -1.09B | 28.60B |
| Operating Cash Flow | 32.82B | 26.65B | 11.18B | 7.72B | 36.34B |
| Investing Cash Flow | -15.72B | -28.73B | -46.30B | 13.23B | 67.20B |
| Financing Cash Flow | -13.56B | -4.14B | -13.48B | -13.46B | -58.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥290.17B | 14.76 | ― | 2.50% | 6.16% | 17.11% | |
73 Outperform | ¥272.54B | 14.24 | ― | 1.65% | 14.49% | -21.17% | |
71 Outperform | ¥496.67B | 28.49 | 5.25% | 2.13% | -2.23% | 130.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥391.31B | 197.68 | 5.94% | 0.56% | 6.22% | ― | |
55 Neutral | ¥538.04B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% | |
54 Neutral | ¥622.19B | 11.29 | 4.83% | 2.95% | -2.67% | -85.21% |